Evidence map›Paper›PMID 19699141›Full record

ArticleJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2009

Outcome of critically ill patients with influenza virus infection.

Guangxi Li, Murat Yilmaz, Marija Kojicic, Evans Fernández-Pérez, Raed Wahab, W Charles Huskins, Bekele Afessa, Jonathon D Truwit, Ognjen Gajic

Abstract read
In one paragraph

Article in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome.American journal of physiology. Lung cellular and molecular physiology · 2016
    Article
  8. Review
  9. Article
  10. Article
  11. Influenza in pregnancy.Influenza and other respiratory viruses · 2013
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Postinfection A77-1726 treatment improves cardiopulmonary function in H1N1 influenza-infected mice.American journal of respiratory cell and molecular biology · 2012
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Guangxi LiDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, United States.
Murat Yilmaz
Marija Kojicic
Evans Fernández-Pérez
Raed Wahab
W Charles Huskins
Bekele Afessa
Jonathon D Truwit
Ognjen Gajic

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfluenza is a major cause of morbidity and mortality, with its greatest burden on the elderly and patients with chronic co-morbidities in the intensive care unit (ICU). An accurate prognosis is essential for decision-making during pandemic as well as interpandemic periods.

methodsA retrospective cohort study was conducted to determine prognostic factors influencing short term outcome of critically ill patients with confirmed influenza virus infection. Baseline characteristics, laboratory and diagnostic findings, ICU interventions and complications were abstracted from medical records using standard definitions and compared between hospital survivors and non-survivors with univariate and multivariate logistic regression analyses.

results111 patients met the inclusion criteria. Acute respiratory distress syndrome (ARDS) complicated ICU course in 25 (23%) of the patients, with mortality rate of 52%. Multivariate logistic regression analysis identified the following predictors of hospital mortality: Acute Physiology and Chronic Health Evaluation (APACHE) III predicted mortality (Odds ratio [OR] 1.49, 95% confidence interval [CI] 1.1-2.1 for 10% increase), ARDS (OR 7.7, 95% CI 2.3-29) and history of immunosuppression (OR 7.19, 95% CI 1.9-28).

conclusionsAPACHE III predicted mortality, the development of ARDS and the history of immunosuppression are independent risk factors for hospital mortality in critically ill patients with confirmed influenza virus infection.

Indexed as

Critical IllnessAgedAged, 80 and overCohort StudiesFemaleHumansInfluenza, HumanIntensive Care UnitsLogistic ModelsMaleMiddle AgedPrognosisRespiratory Distress SyndromeRetrospective Studies

Identifiers

PMID19699141
PMCPMC7108217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.